Presented by Giustino Di Pretoro, Associate Director of Drug Product Development at Johnson and Johnson And Dr Robin Meier, Manager Scientific Operations at L.B. Bohle Maschinen.
Discussion Objectives:
1. What is Drug Product Continuous Manufacturing?
2. Is Continuous Manufacturing really worth the effort? “without data, you are just another person with an opinion”
3. What are the challenges of implementing CM?
4. Development and tech transfer considerations for CM.
Learning Objectives:
1. Demonstrate financial and operational benefits of Continuous Manufacturing.
2. Explain the key challenges in the implementation of CM in R&D
3. Explore key strategies in drug product development of CM
